astrazeneca

The expansion includes nearly 1,300 positions focused on driving innovation, improving efficiency and optimizing operations across the global company.The expanded facilities were inaugurated in a ceremony officiated by Tamil Nadu Industries Minister T.R.B. Rajaa, British Deputy High...

New Delhi: After pharmaceutical giant AstraZeneca admitted in a US court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday took an in-depth look at the safety of the Covishield vaccine manufactured by the Serum Institute of India. Considered from...

Lucknow, Samajwadi Party chief Akhilesh Yadav on Thursday accused the BJP of putting the lives of his countrymen at risk after UK-based pharmaceutical company AstraZeneca initiated a global recall of its COVID-19 vaccine, which Was introduced in India as 'Covishield'."The Corona vaccine...

New Delhi, UK-based pharmaceutical major AstraZeneca has started withdrawing its Covid-19 vaccine, which was provided in India as 'Covishield' in partnership with the Serum Institute of India, days after it released a blood test... Had acknowledged the rare side effects of clotting and reducing...

AstraZeneca has voluntarily withdrawn the "marketing authorization" of its Covid vaccine, sold as Covishield in India and Vaxzevria in Europe.In a statement to IANS, an SII spokesperson said that with India achieving higher vaccination rates in 2021 and 2022, as well as the emergence of new...

Its COVID-19 vaccine, developed in collaboration with Oxford University, has been recalled worldwide after the drugmaker admitted in a US court in February about its potential side effects. (TTS), a rare blood clotting disorder.AstraZeneca voluntarily withdrew “market authorization” of its...

London/New Delhi, UK-based pharmaceutical major AstraZeneca has started a global recall of its COVID-19 vaccine, which it provided in India as 'Covishield' in partnership with the Serum Institute of India. A few days after admitting the rare side effect of blood clotting was a low platelet...

New Delhi, UK-based pharmaceutical major AstraZeneca has started withdrawing its COVID-19 vaccine, which was provided in India as Covishield in partnership with the Serum Institute of India, over concerns about blood clotting. And a few days after acknowledging the rare side effects of low...

The company voluntarily withdrew the "marketing authorization" of its Covi vaccine, which was sold as Covishield in India and Vaxzevria in Europe. According to the Telegraph report, it will no longer be used in the European Union.While the company had applied to withdraw the vaccine on March...

New Delhi [India], Following the worldwide withdrawal of the AstraZeneca COVID-19 vaccine, Aam Aadmi Party leader Saurabh Bhardwaj on Wednesday questioned the Center as to why it allowed the Covishield vaccine while most European countries It was banned due to its side effects. Saurabh said...

Cambridge [UK]: Pharmaceutical giant AstraZeneca's COVID-19 vaccine has been withdrawn worldwide after the company admitted for the first time in court documents that it was carrying a rare and potentially lethal vaccine, reports British newspaper 'The Telegraph'. Can cause dangerous side...

New Delhi, Amid AstraZeneca's entry, Bharat Biotech on Thursday claimed that its Covid-19 vaccine Covaxy is safe and devoid of any side effects as Covishield can cause complications in rare cases.In a statement, the company said Covaxin was developed focusing on safety first, followed by...

The Hyderabad-based company issued a statement amid questions being raised in some quarters over the safety of Covid vaccines after global drugmaker AstraZeneca admitted that its Covid vaccine Covishield, developed by researchers at the University of Oxford, may cause a blood clotting disorder...

New Delhi [India], Amid reports of possible rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which has developed Covaxin, said in a statement that the vaccine will be developed "with a focus on safety first." "Together" will be developed. It said Covaxin was the...

Ahmedabad, May 1 () The opposition Congress on Wednesday alleged that the BJ government at the Center has not followed World Health Organization (WHO) guidelines, and demanded that those who died due to heart attacks or similar causes be compensated. Compensation should be given to relatives who...

New Delhi: A petition was filed in the Supreme Court on Wednesday seeking the formation of a medical expert panel under the supervision of a retired Supreme Court judge to investigate any possible side effects and risk factors of the Covishield vaccine.UK-headquartered pharmaceutical company...

In the application filed by lawyer Vishal Tiwari, it has been said that after Covid-19, cases of death due to heart attack among youth have increased and people have died suddenly and a demand has been made to give instructions to the Central Government. This has been done to establish vaccine...

New Delhi: Delhi Health Minister Saurabh Bhardwaj on Wednesday said "rare side effects" of the Covishield vaccine need to be dealt with on a war footing and alleged that the central government has done nothing in the matter so far.At a press conference, Bhardwaj said the Center should talk to...

Lucknow: Amid the controversy over "side effects" of the Covishield vaccine, Samajwadi Party chief Akhilesh Yadav on Wednesday accused the BJP of putting people's lives at stake to "extort political donations" from a vaccine manufacturer.Demanding a high-level judicial inquiry into this, Yadav...

Cambridge [United Kingdom], In light of recent concerns about possible rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the Pharmaceutica giant has reiterated its commitment to patient safety while emphasizing the overall safety profile of the vaccine. . An AstraZeneca spokesperson...